C12N 2710/22023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2710/22023 (Virus like particles [vlp]) appears on 31 US grants and 54 published applications in this corpus.
Search patents in C12N- Granted patents
- 31
- Published applications
- 54
- Assignees
- 38
- Inventors
- 101
- Latest grant
- 27 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 1 | 2 |
| 2005 | 0 | 2 |
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 1 | 2 |
| 2009 | 1 | 4 |
| 2010 | 1 | 3 |
| 2011 | 1 | 3 |
| 2012 | 1 | 4 |
| 2013 | 2 | 0 |
| 2014 | 3 | 6 |
| 2015 | 2 | 2 |
| 2016 | 0 | 2 |
| 2017 | 3 | 4 |
| 2018 | 4 | 3 |
| 2019 | 2 | 2 |
| 2020 | 0 | 2 |
| 2021 | 2 | 2 |
| 2022 | 2 | 2 |
| 2023 | 0 | 3 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleic acid origami structure encapsulated by capsid units27 May 2025US 12,312,594 B2Geza Ad Ltd.
- Drug delivery system based on JCV-VLP5 Apr 2022US 11,291,735 B2Life Science Inkubator Betriebs GmbH & Co. KG
- Drug delivery system and methods providing thereof22 Mar 2022US 11,279,938 B2NEUWAY Pharma GmbH
- Immunity inducer4 May 2021US 10,994,007 B2Saitama Medical University
- Retargeting of viruses or VLPs13 Apr 2021US 10,975,359 B2Deutsches Primatenzentrum GmbH Leibniz-Institut für Primatenforschung
- Method for production of virus-like particles for gene delivery27 Aug 2026US 2026/0250644 A1Carnegie Mellon University
- Vlp for the treatment of leukodystrophies5 Oct 2023US 2023/0310652 A1NEUWAY Pharma GmbH
- A method for providing a vlp derived from john cunningham virus25 May 2023US 2023/0157972 A1NEUWAY Pharma GmbH
- Vlp for the treatment of a lysosomal storage disease25 May 2023US 2023/0159938 A1NEUWAY Pharma GmbH
- Methods and compositions for inhibiting polyomavirus-associated pathology15 Dec 2022US 2022/0395569 A1The United States of America, as represented by the Secretary, Dept. of Health and Human Services
Most cited
By later US patents
- Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments39US 4,950,599 A1990
- Virus-like particles for the induction of autoantibodies28US 6,719,978 B2The United States of America as represented by the Department of Health and Human Services · 2004
- Method for producing chimeric polypeptides22US 6,437,095 B1Hoffmann-La Roche Inc. · 2002
- Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles20US 8,729,038 B22014
- SV-40 derived DNA constructs comprising exogenous DNA sequences12US 6,090,608 AHadasit Medical Research Services and Development Ltd. · 2000